Missing photo

Lilia RC Pedrosa

Short bio & current area(s) of interest
Lilia Pedrosa has a degree in Pharmaceutical Sciences (2000-2005) from the Faculty of Pharmacy at University of Coimbra. During her 6-year PharmD degree studies she experienced 1-year abroad at University of Barcelona (Spain) and a summer internship at the Hospital in Czech Republic, as a pharmacist. Lilia started her path in Research in 2008 as a Researcher in the project “The increase in the bioavailability of oral insulin through the nanoencapsulation into polysaccharides” at University of Coimbra. In 2007, Lilia followed a Post Graduation in “Pharmacy and the Medicine Law”, Biomedical Law Centre of the Faculty of Law of the University of Coimbra starting in parallel to her first job as PharmD – Regularity Affairs Officer. By the dynamic and ambitious personality, Lilia started her PhD in 2009 at Erasmus Medical Center-Rotterdam and Netherlands Cancer Institute-Amsterdam, The Netherlands), where she worked in close collaboration with a biotech company CERONCO. In 2014, Lilia concluded her PhD in Nanomedicine/Oncology, finalizing her project with a thesis entitled of “Liposomal Nanomedicine with Short Chain Sphingolipids Modulate Tumor Cell Membrane Permeability and Improve Chemotherapy”. Following 9-yerars of international experience, Lilia worked within Pharma for 3-years. In 2014-2015 at BBB Therapeutics (The Netherlands) as a Scientist Target CNS and in 2016-2018 at ProQR Therapeutics (The Netherlands), focusing on development of drugs to treat severe genetic disorders, as a Scientist Pharmaceutics. Back home, in Portugal since 2018, Lilia performed as a Post-Doc at Champalimaud Foundation within Immunology and lately at Faculty of Pharmacy in University of Lisbon (2019-2021), at Toxicology department in the field of CNS diseases developing nanotherapeutic formulations to treat Glioblastoma.

BSc/MSc (2006) in Pharmaceutical Sciences, Faculty of Pharmacy Universidade de Coimbra, Portugal

PhD (2014) in Nanotechnology (Oncology), Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands

Postdoctoral Fellow (2018), Champalimaud Foundation, Lisbon, Portugal

Researcher, iMed.ULisboa, Faculty of Pharmacy Universidade de Lisboa, Lisbon, Portugal and BBB-Therapeutics BV, Leiden, The Netherlands

Back To Top
Come meet us at

Faculdade de Farmácia da Universidade de Lisboa | Av. Professor Gama Pinto
1649-003 Lisboa | Portugal

Phone | +351 217 946 400
Fax | +351 217 946 470
Web | www.imed.ulisboa.pt
Email | imed.ulisboa@ff.ulisboa.pt